Plot 17, Hannington Rd, Crested Towers, Floor 9
+256 414 347063
reap@finance.go.ug
As one of the efforts to improve population health, the National Community Health Program implementation set major priority actions for the period 2024, which include Community health governance and coordination structures at the sub-national level created/reactivated...
In a statement released recently the Global Fund Executive Director Peter Sands, applauded the significant progress highlighted in the new UNAIDS report, particularly the increased number of people currently on treatment for HIV. According to the report, in 2023, 77%...
A recent study that conducted by one of the Global Fund Sub recipients in Uganda (PACE - Programme for Accessible health, Communication and Education) has revealed insights that are among others expected to improve net handling and care. The study sought to assess the...
Since 2015, lives of over 560,0000 Ugandans have been saved through diagnosis and treatment, according to the Ministry of Health. This achievement is largely attributed government and its partners and stakeholders, such as the Global Fund among others who have been...
By Dr. Mohammed Yassin - Senior TB Advisor, the Global Fund It appears new, life-changing technologies come on the scene more and more with each passing year. In November 2022, the artificial intelligence (AI) tool ChatGPT dominated global headlines; by January 2023,...
The Global Fund - Uganda Monthly Performance Review meeting was held earlier this month at the Ministry of Health headquarters in Kampala. The meeting sought to review the operations of the Global Fund Grant, with the intention of improving programme implementation of...
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) is launching a new Revolving Facility to negotiate improved supply terms for global health products for the countries it supports. According to a news report published by the Global Fund on...
Through its competitive tenders, the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), together with its partners and generic pharmaceutical manufacturers, will be able to offer tenofovir disoproxil fumarate, lamivudine and dolutegravir (TLD), a...
The National Funding Model IV Global Fund Facility grant writing exercise kicked off in earnest last month and was currently in its third week by 6th February 2023. Spearheaded by the Country Coordinating Mechanism (CCM) of the Global Fund, the exercise is focused on...
Key results for the previous year (2021) in countries where the Global Fund invests include: For HIV:23.3 million people received lifesaving antiretroviral therapy for HIV, continuing the trend of a rising number of people on treatment for the virus.69% of people...
